American Strategic Investment (NYC) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on June 2, 2026, with voting on director elections, auditor ratification, and a say-on-pay proposal.
Proxy materials are distributed via internet access, with options for paper copies upon request.
Stockholders of record as of April 10, 2026, are entitled to vote on all matters.
The Board encourages prompt voting to avoid additional solicitation expenses.
Voting matters and shareholder proposals
Stockholders will vote on electing two Class III directors, ratifying CBIZ as the independent auditor for 2026, and a non-binding advisory resolution on executive compensation.
The Board recommends voting FOR all proposals.
Procedures for submitting shareholder proposals and director nominations for the 2027 meeting are outlined, with specific deadlines and requirements.
Board of directors and corporate governance
The Board consists of four members: three independent directors and one managing director.
Directors are divided into three classes with staggered three-year terms.
The Board has audit, compensation, and nominating/corporate governance committees, all composed of independent directors.
The lead independent director role is held by Ms. Tuppeny, providing additional oversight and balance.
The Board and committees met regularly in 2025, with full attendance.
Latest events from American Strategic Investment
- Net loss narrowed and liquidity challenges persist amid NYC office market headwinds.NYC
Q2 2026 - Revenue fell to $7.3M as losses narrowed and portfolio remained 76.4% leased.NYC
Q1 2026 - Virtual 2026 meeting to vote on directors, auditor, and executive pay, with online participation.NYC
Proxy filing - 2025 saw lower revenue from asset sales but improved net loss and stable 80.3% occupancy.NYC
Q4 2025 - Annual meeting to vote on director, auditor, and say-on-pay, with all proposals recommended for approval.NYC
Proxy Filing - Virtual annual meeting to vote on director, auditor, and executive pay on May 29, 2025.NYC
Proxy Filing - Q3 net loss rose on impairments; 9 Times Square sale to cut leverage and boost diversification.NYC
Q3 2024 - $91.9M net loss on $84.7M impairment, $63.5M sale pending, EBITDA and occupancy up.NYC
Q2 2024 - Net loss narrowed in Q4 2024 as asset sales improved leverage and a new CEO was appointed.NYC
Q4 2024